Schneider Joel Solomon Zev 4
4 · Solid Biosciences Inc. · Filed Mar 15, 2021
Insider Transaction Report
Form 4
Schneider Joel Solomon Zev
Chief Operating Officer
Transactions
- Sale
Common Stock
[F1]2021-03-12$8.84/sh−11,699$103,468→ 280,473 total - Sale
Common Stock
[F1]2021-03-12$8.84/sh−11,699$103,452→ 268,774 total
Footnotes (1)
- [F1]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1) adopted by the reporting person on May 12, 2020.
Signature
/s/ by Erin P. Brennan as attorney-in-fact for Joel Solomon Zev Schneider|2021-03-15